11.07.2015 Views

Judy K. Ball, Ph.D., M.P.A. Office of Applied Studies Substance ...

Judy K. Ball, Ph.D., M.P.A. Office of Applied Studies Substance ...

Judy K. Ball, Ph.D., M.P.A. Office of Applied Studies Substance ...

SHOW MORE
SHOW LESS
  • No tags were found...

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Judy</strong> K. <strong>Ball</strong>, <strong>Ph</strong>.D., M.P.A.<strong>Office</strong> <strong>of</strong> <strong>Applied</strong> <strong>Studies</strong><strong>Substance</strong> Abuse & Mental Health Services Administration29 March 2005


Continuum <strong>of</strong> Drug InvolvementDrug-related ED visitsDruguseDrugmisuseDrugabuse• Suicide attempt• Underage drinking• Seeking detox• Misuse/abuse– Overmedication– Malicious poisoning– All other


DAWN Hospitals, Q3-Q4 2003Hospitals in sample 518Participating 260Total eligible hospitals4,55850%Source: SAMHSA/OAS. Drug Abuse Warning Network, 2003: Interim NationalEstimates <strong>of</strong> Drug-related Emergency Department Visits. DAWN Series D-26, DHHSPub. No. (SMA) 04-3972. Rockville, MD, 2004.


Opiates/Opioids, Q3-Q4 2003ED visits20,000Misuse/abuse15,00017,04413,61110,0008,94610,7385,0006,2813,6000Hydrocodone/combinationsOxycodone/combinationsMethadoneSource: DAWN Estimates for Coterminous U.S.


Opiates/Opioids, Q3-Q4 2003ED visits20,000Misuse/abuse15,00010,0005,00003,259765 285Fentanyl/combinations1,509HydromorphoneSource: DAWN Estimates for Coterminous U.S.


Opiates/Opioids, Q3-Q4 2003ED visits20,000Seeking detox15,00017,06213,68810,0006,8815,00001,4962,2881,169Hydrocodone/combinationsOxycodone/combinationsMethadoneSource: DAWN Estimates for Coterminous U.S.


DAWN Hospitals, 2004Hospitals in new sample 903Participating* 436Total eligible hospitals4,55848%*Preliminary figures


Opiate/Opioid Reports, 2004Misuse/abuseReports to date0 1,000 2,000 3,000 4,000 5,000Fentanyl*627Hydrocodone*4,879Hydromorphone305Oxycodone*4,486Methdaone4,620* Single and multi-ingredient formulationsSource: DAWN Live! 3/11/2005


Single- vs. Multi-drug VisitsMisuse/abuseMulti53%Multi80%Multi70%Fentanyl*Hydrocodone*HydromorphoneMulti66%Multi60%Source: DAWN, 3/7/2005Oxycodone*Methadone


Opiate/Opioid Reports, 2004Seeking detoxReports to date0 1,000 2,000 3,000 4,000 5,000Fentanyl*122Hydrocodone*1,528Hydromorphone199Oxycodone*2,581Methdaone1,761* Single and multi-ingredient formulationsSource: DAWN Live! 3/11/2005


Single- vs. Multi-drug VisitsSeeking detoxMulti74%Multi78%Multi80%Fentanyl*Hydrocodone*HydromorphoneMulti70%Multi50%Source: DAWN, 3/7/2005Oxycodone*Methadone


Two Sides <strong>of</strong> New DAWN• Annual estimates for U.S. & selected metros– Rigorous methods– Known precision• Surveillance data– Sentinel events– Incomplete, ? generalizable ?– Balance + and -• Don’t know what we don’t know• Know what we can know quickly


http://DAWNinfo.samhsa.gov

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!